These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17998543)

  • 1. ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.
    Zou JX; Revenko AS; Li LB; Gemo AT; Chen HW
    Proc Natl Acad Sci U S A; 2007 Nov; 104(46):18067-72. PubMed ID: 17998543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark.
    Revenko AS; Kalashnikova EV; Gemo AT; Zou JX; Chen HW
    Mol Cell Biol; 2010 Nov; 30(22):5260-72. PubMed ID: 20855524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated E2F and the AAA+ coregulator ANCCA drive proto-oncogene ACTR/AIB1 overexpression in breast cancer.
    Hsia EY; Kalashnikova EV; Revenko AS; Zou JX; Borowsky AD; Chen HW
    Mol Cancer Res; 2010 Feb; 8(2):183-93. PubMed ID: 20124470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinesin family deregulation coordinated by bromodomain protein ANCCA and histone methyltransferase MLL for breast cancer cell growth, survival, and tamoxifen resistance.
    Zou JX; Duan Z; Wang J; Sokolov A; Xu J; Chen CZ; Li JJ; Chen HW
    Mol Cancer Res; 2014 Apr; 12(4):539-49. PubMed ID: 24391143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2.
    Kalashnikova EV; Revenko AS; Gemo AT; Andrews NP; Tepper CG; Zou JX; Cardiff RD; Borowsky AD; Chen HW
    Cancer Res; 2010 Nov; 70(22):9402-12. PubMed ID: 20864510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.
    Zou JX; Guo L; Revenko AS; Tepper CG; Gemo AT; Kung HJ; Chen HW
    Cancer Res; 2009 Apr; 69(8):3339-46. PubMed ID: 19318566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting bromodomain protein ANCCA/ATAD2 enhances the efficacy of DNA‑damaging chemotherapy agents and radiation.
    Duan Z; Andrews NP; Chen CZ; Fan M; Wang J; Shen J; Li JJ; Chen HW
    Oncol Rep; 2020 Jan; 43(1):318-327. PubMed ID: 31789405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
    Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.
    Wen J; Li R; Lu Y; Shupnik MA
    Oncogene; 2009 Jan; 28(4):575-86. PubMed ID: 18997820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding.
    Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS
    Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
    Karmakar S; Foster EA; Smith CL
    Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediator and p300/CBP-steroid receptor coactivator complexes have distinct roles, but function synergistically, during estrogen receptor alpha-dependent transcription with chromatin templates.
    Acevedo ML; Kraus WL
    Mol Cell Biol; 2003 Jan; 23(1):335-48. PubMed ID: 12482985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin.
    Ceschin DG; Walia M; Wenk SS; Duboé C; Gaudon C; Xiao Y; Fauquier L; Sankar M; Vandel L; Gronemeyer H
    Genes Dev; 2011 Jun; 25(11):1132-46. PubMed ID: 21632823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H4K12ac is regulated by estrogen receptor-alpha and is associated with BRD4 function and inducible transcription.
    Nagarajan S; Benito E; Fischer A; Johnsen SA
    Oncotarget; 2015 Mar; 6(9):7305-17. PubMed ID: 25788266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
    Matthews J; Wihlén B; Thomsen J; Gustafsson JA
    Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
    O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
    Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
    Ku TK; Crowe DL
    J Endocrinol; 2007 Apr; 193(1):147-55. PubMed ID: 17400812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.